Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blind, Parallel Controlled Phase I Clinical Trial to Evaluate the Safety and Preliminary Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Population Aged 2 Years and Older

NCT05815264 is registered in ClinicalTrials.gov with Ab&B Bio-tech Co., Ltd.JS as lead sponsor.

NCT NCT05815264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05815264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blind, Parallel Controlled Phase I Clinical Trial to Evaluate the Safety and Preliminary Immunogenicity of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Population Aged 2 Years and Older
Lead sponsor
Ab&B Bio-tech Co., Ltd.JS
Phase
Phase 1
Overall status
Completed
Start date
September 7, 2020
Completion date
April 6, 2021
Enrollment
144 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia